Comparison of the efficacy and safety of sedation protocols with the use of dexmedetomidine–remifentanil and propofol–remifentanil during percutaneous closure of atrial septal defects: a randomized clinical trial

Peer Review reports

Original Submission
20 Jun 2021	Submitted	Original manuscript
1 Aug 2021	Reviewed	Reviewer Report - Rodrigo Leal Alves
9 Feb 2022	Author responded	Author comments - Xiao-Lan Chen
Resubmission - Version 2
9 Feb 2022	Submitted	Manuscript version 2
23 Mar 2022	Reviewed	Reviewer Report - Marek Rudnicki
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
17 Apr 2022	Editorially accepted
3 May 2022	Article published	10.1186/s13019-022-01834-6

Back to article page